Antidote Health confirmed it has laid off staffers this week, about seven months after the telehealth startup announced its $22 million Series A round of funding.
According to reporting by Calcalist, the company has let go of about a third of its workforce, with most cuts coming from its research and development team. Antidote offers virtual primary care, mental healthcare and hypertension...
Nucleai, maker of an AI-powered pathology platform that aims to predict a patient's response to treatment, announced Tuesday it had raised $33 million in Series B funding.
The round was led by Section 32 and Sanofi Ventures, with participation from existing investors including Debiopharm, Fosun RZ Capital, Vertex Ventures and Grove Ventures. The startup said the latest round brings its total...
